BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang S, Liu Y, Chen J, Shu H, Shen S, Li Y, Lu X, Cao X, Dong L, Shi J, Cao Y, Wang X, Zhou J, Liu Y, Chen L, Fan J, Ding G, Gao Q. Autoantibody signature in hepatocellular carcinoma using seromics. J Hematol Oncol 2020;13:85. [PMID: 32616055 DOI: 10.1186/s13045-020-00918-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Lei Q, Yu C, Li Y, Hou H, Xu Z, Yao Z, Zhang Y, Lai D, Ndzouboukou JB, Zhang B, Chen H, Ouyang Z, Xue J, Lin X, Zheng Y, Wang X, Jiang H, Zhang H, Qi H, Guo S, He M, Sun Z, Wang F, Tao S, Fan X. Anti-SARS-CoV-2 IgG responses are powerful predicting signatures for the outcome of COVID-19 patients. Journal of Advanced Research 2021. [DOI: 10.1016/j.jare.2021.11.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Lin N, Lin Y, Xu J, Liu D, Li D, Meng H, Gallant MA, Kubota N, Roy D, Li JS, Gorospe EC, Sherman M, Gish RG, Abou-Alfa GK, Nguyen MH, Taggart DJ, Van Etten RA, Hoshida Y, Li W. A multi-analyte cell-free DNA-based blood test for early detection of hepatocellular carcinoma. Hepatol Commun 2022. [PMID: 35244350 DOI: 10.1002/hep4.1918] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Luo R, Zheng C, Song W, Tan Q, Shi Y, Han X. High-throughput and multi-phases identification of autoantibodies in diagnosing early-stage breast cancer and subtypes. Cancer Sci 2021. [PMID: 34843149 DOI: 10.1111/cas.15227] [Reference Citation Analysis]
4 Yan H, Qiu Z, Xiang Z, Feng K, Huang M, Gao F. TIPS improves outcomes in patients with HCC and symptomatic portal hypertension: a multi-institution experience. Cancer Imaging 2022;22. [DOI: 10.1186/s40644-022-00451-9] [Reference Citation Analysis]
5 Chen F, Wang J, Wu Y, Gao Q, Zhang S. Potential Biomarkers for Liver Cancer Diagnosis Based on Multi-Omics Strategy. Front Oncol 2022;12:822449. [DOI: 10.3389/fonc.2022.822449] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Clendenen TV, Hu S, Afanasyeva Y, Askenazi M, Koenig KL, Hulett T, Liu M, Liu S, Wu F, Zeleniuch-Jacquotte A, Chen Y. Temporal reproducibility of IgG and IgM autoantibodies in serum from healthy women. Sci Rep 2022;12:6192. [PMID: 35418192 DOI: 10.1038/s41598-022-10174-3] [Reference Citation Analysis]
7 Qiu C, Wang B, Wang P, Wang X, Ma Y, Dai L, Shi J, Wang K, Sun G, Ye H, Zhang J. Identification of novel autoantibody signatures and evaluation of a panel of autoantibodies in breast cancer. Cancer Sci 2021;112:3388-400. [PMID: 34115421 DOI: 10.1111/cas.15021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Wang T, Huang XY, Zheng SJ, Liu YY, Chen SS, Ren F, Lu J, Duan ZP, Liu M. Serum Anti-14-3-3 Zeta Autoantibody as a Biomarker for Predicting Hepatocarcinogenesis. Front Oncol 2021;11:733680. [PMID: 34722278 DOI: 10.3389/fonc.2021.733680] [Reference Citation Analysis]